Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20360317 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Relapse Prevention for Bipolar Type-II Disorder
Conditions: Bipolar Disorder;   Depression
Interventions: Drug: Fluoxetine;   Drug: Lithium

Indicates status has not been verified in more than two years